Effect of 25‐Gauge Needle–Assisted Phacoemulsification of Dislocated Intravitreal Lens Nucleus

Purpose Purpose: To present and evaluate the effect of a novel technique, 25‐gauge (G) needle–assisted phacoemulsification, to remove dislocated intravitreal lens nuclei. Methods Methods: Nine eyes of nine patients with dislocated intravitreal lens nuclei who underwent 23‐G pars plana vitrectomy (PPV) and 25‐G needle–assisted phacoemulsification between July 2022 and September 2024 were included in this study. Best‐corrected visual acuity (BCVA), intraocular pressure (IOP) and corneal endothelial cell count (CECC) were statistically analysed both preoperatively and postoperatively. The intraoperative and postoperative complications were evaluated. A minimum follow‐up of 6 months was completed for all eyes. Results Results: All nine eyes of nine patients were successfully treated with 23‐G PPV and 25‐G needle–assisted phacoemulsification and postoperatively followed up for 6–13 months. BCVA improved significantly ( p < 0.05) in all patients, and postoperative IOP was 16.0 ± 1.73 mmHg, remaining stable within the normal range. Although statistical differences were observed between preoperative and final follow‐up, the loss rate of CECC was within a tolerable range. No intraoperative and postoperative complications, such as iatrogenic retinal tears or vitreous haemorrhage, were observed. Conclusion Conclusion: The 25‐G needle–assisted phacoemulsification is a safe and efficient alternative for removing dislocated intravitreal lens nuclei. Trial Registration: ClinicalTrials.gov identifier: NCT06709378